Nuvig Therapeutics, Inc.

1775 Woodside Rd., Suite 201
Redwood City
United States

Tel: 650-394-3990


Featured Employer
Show jobs for this employer

About Nuvig Therapeutics, Inc.

Nuvig Therapeutics, Inc., headquartered in Redwood City, CA is an IND-enabling stage development company focused on fundamentally transforming treatments for inflammatory and autoimmune diseases. Our Development Candidate NVG-2089 is a novel, recombinant human IgG1 Fc modulator that binds anti-inflammatory receptors, upregulates an immune checkpoint and expands T reg cells for the treatment of autoimmune diseases. Pipelines efforts are focused on engineering full-length therapeutic antibodies with our technology to maximize their ability to control aggressive autoimmune diseases. The company was founded in 2021 by industry veterans who closed a $47 million Series A financing, led by Novo Holdings A/S and Platanus, joined by Bristol Myers Squibb, Digitalis Ventures, and Mission BioCapital.

At Nuvig, we believe that a empathic, diverse, collaborative, accountable and pragmatic culture is key to our success. We are seeking individuals seeking to make a real impact to a dynamic, fast-paced and early stage company to fundamentally improve the lives of patients living with autoimmune diseases.  



3 articles about Nuvig Therapeutics, Inc.